BREAKFAST SESSION - 8:00 – 8:30 am
Landscape of Bariatric Surgery in the Times of GLP1s
Session Objectives:
- Learn the most recent bariatric surgery numbers and trends
- Understand the adoption of new 2022 ASMBS/IFSO guidelines
- Describe the impact of new GLP-1s in bariatric surgery volume
- Assess the multiple scenarios where obesity medicine can be combined with bariatric surgery
- Recognize the future pipeline of incretin-based medications
Speaker
Dr. Jaime Ponce, MD, FACS, FASMBS, FIFSO, DABS-FPMBS, DABOM
Medical Director of Bariatric Surgery and Obesity Medicine
CHI Memorial Hospital in Chattanooga, Tennessee, United States.
Medical Director of Bariatric Surgery and Obesity Medicine at CHI Memorial Hospital in Chattanooga Tennessee, USA. Past-President of ASMBS (2012-2013), current President of the IFSO North American Chapter (2021-2024), former Chair of the ASMBS Insurance committee, member of the Executive Council of the ASMBS (2009-2016), served as Chair of the Bariatric Surgical Review Committee, Member of the IFSO Executive Board (2013-2016/2021-2024), AOA, Diplomat of the ABOM and FPD, has been given Honorary Membership internationally including the Brazilian, Spanish, Mexican bariatric surgery societies, Principal Investigator in eleven FDA clinical trials for obesity medical devices, recipient of the ASMBS Foundation Master Educator Award (2018) and Outstanding Lifetime Achievement Award (2023), and now chair of the Bariatric Certification Committee (2023-2025) working with the American Board of Surgery to develop the Focus Practice Designation in Metabolic Bariatric Surgery.